Adaptation is mandatory for intensity modulated proton therapy of advanced lung cancer to ensure target coverage.
暂无分享,去创建一个
Markus Alber | Lone Hoffmann | Ditte Sloth Møller | M. Alber | D. Møller | L. Hoffmann | M. F. Jensen | Marianne Ingerslev Holt | Maria Fuglsang Jensen | M. Holt
[1] Martin Stuschke,et al. Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[2] Suresh Senan,et al. Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer. , 2005, International journal of radiation oncology, biology, physics.
[3] Dietmar Georg,et al. Adaptive radiation therapy. , 2018, Zeitschrift fur medizinische Physik.
[4] Matthias Fippel,et al. A pencil beam algorithm for intensity modulated proton therapy derived from Monte Carlo simulations , 2005, Physics in medicine and biology.
[5] Jan-Jakob Sonke,et al. Adaptive radiotherapy for lung cancer. , 2010, Seminars in radiation oncology.
[6] Lei Dong,et al. Physics controversies in proton therapy. , 2013, Seminars in radiation oncology.
[7] Anders Forsgren,et al. Minimax optimization for handling range and setup uncertainties in proton therapy. , 2011, Medical physics.
[8] Jan-Jakob Sonke,et al. Intra thoracic anatomical changes in lung cancer patients during the course of radiotherapy. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] Lone Hoffmann,et al. Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patients , 2010, Acta oncologica.
[10] Jose Belderbos,et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Joe Y. Chang,et al. Clinical controversies: proton therapy for thoracic tumors. , 2013, Seminars in radiation oncology.
[12] Radhe Mohan,et al. Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer. , 2012, International journal of radiation oncology, biology, physics.
[13] Joe Y. Chang,et al. Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer. , 2011, International journal of radiation oncology, biology, physics.
[14] Radhe Mohan,et al. Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study. , 2010, International journal of radiation oncology, biology, physics.
[15] Joe Y. Chang,et al. Adaptive Radiation for Lung Cancer , 2010, Journal of oncology.
[16] P. Poulsen,et al. Dosimetric impact of respiratory motion, interfraction baseline shifts, and anatomical changes in radiotherapy of non-small cell lung cancer , 2013, Acta oncologica.
[17] Lone Hoffmann,et al. Clinical outcome of image-guided adaptive radiotherapy in the treatment of lung cancer patients , 2015, Acta oncologica.
[18] Markus Alber,et al. Adaptive radiotherapy for advanced lung cancer ensures target coverage and decreases lung dose. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[19] Frank Verhaegen,et al. Results of a Multicentric In Silico Clinical Trial (ROCOCO): Comparing Radiotherapy with Photons and Protons for Non-small Cell Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[20] Mauro Iori,et al. Testing of the analytical anisotropic algorithm for photon dose calculation. , 2006, Medical physics.
[21] M. Herk. Errors and margins in radiotherapy. , 2004 .
[22] Lone Hoffmann,et al. Anatomical landmarks accurately determine interfractional lymph node shifts during radiotherapy of lung cancer patients. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[23] Wei Liu,et al. Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[24] W. Curran,et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. , 2015, The Lancet. Oncology.
[25] George Starkschall,et al. Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer. , 2008, International journal of radiation oncology, biology, physics.
[26] Jan-Jakob Sonke,et al. Effects of anatomical changes on pencil beam scanning proton plans in locally advanced NSCLC patients. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[27] Radhe Mohan,et al. Robust optimization of intensity modulated proton therapy. , 2012, Medical physics.
[28] Lone Hoffmann,et al. Adaptive radiotherapy of lung cancer patients with pleural effusion or atelectasis. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[29] Jan-Jakob Sonke,et al. Mid-ventilation CT scan construction from four-dimensional respiration-correlated CT scans for radiotherapy planning of lung cancer patients. , 2006, International journal of radiation oncology, biology, physics.
[30] Timothy Solberg,et al. Particle Therapy for Non-Small Cell Lung Tumors: Where Do We Stand? A Systematic Review of the Literature , 2014, Front. Oncol..
[31] Heng Li,et al. Selective robust optimization: A new intensity-modulated proton therapy optimization strategy. , 2015, Medical physics.
[32] Heng Li,et al. Clinical implementation of intensity modulated proton therapy for thoracic malignancies. , 2014, International journal of radiation oncology, biology, physics.
[33] Xiaodong Zhang,et al. Reducing Dose Uncertainty for Spot-Scanning Proton Beam Therapy of Moving Tumors by Optimizing the Spot Delivery Sequence. , 2015, International journal of radiation oncology, biology, physics.
[34] Joe Y. Chang,et al. Consequences of anatomic changes and respiratory motion on radiation dose distributions in conformal radiotherapy for locally advanced non-small-cell lung cancer. , 2009, International journal of radiation oncology, biology, physics.
[35] M. Martel,et al. Radiation dose-volume effects in the lung. , 2010, International journal of radiation oncology, biology, physics.
[36] U Oelfke,et al. Worst case optimization: a method to account for uncertainties in the optimization of intensity modulated proton therapy , 2008, Physics in medicine and biology.